The Tap Block Technique Via the Anterior Approach in Elective Surgery of the Spine (TAPBloc Rachis)

University Hospital Center (CHU) Dijon Bourgogne

Status and phase: Completed; Phase 4

Conditions: Elective Surgery of the Spine by Laparotomy

Treatments: Drug: Ropivacaine 0.2%; Drug: Chlorure de sodium 0.9%

Study type: Interventional

Funder types: Other

Identifiers

NCT02055664

MIREK 2013

Details and patient eligibility

About

This is a prospective, single-centre, randomised, double-blind trial, comparing TAP block with continuous infiltration of ropivacaine versus placebo.

Procedure:

Once consent has been obtained, patients will be randomised into one of the two groups: Ropivacaine or Placebo. At the end of the operation, the TAP block will be implemented via a catheter inserted by the anaesthetist.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over 18 yo who have provided written informed consent
• Patients with an indication for elective spinal surgery using laparotomy
• Patients with national health insurance cover

Exclusion criteria

• Adults under guardianship
• Pregnant or breast-feeding women
• allergies or contra-indication for paracetamol, morphine-based drugs
• Contra-indication for ropivacaine
• Contra-indication for sodium chloride
• inability to understand PCA (patient-controlled anaesthesia)
• Hypersensitivity to ropivacaine or to other aminoamide local anaesthetics
• Hypovolemia

Trial design

80 participants in 2 patient groups, including a placebo group

treatment

Experimental group

Treatment:

Drug: Chlorure de sodium 0.9%

control

Placebo Comparator group

Treatment:

Drug: Ropivacaine 0.2%